TVRD Latest Headlines

Analysts Offer Insights on Healthcare Companies: Inhibikase Therapeutics (IKT), Tvardi Therapeutics (TVRD) and Apogee Therapeutics (APGE)

at www.tipranks.com (Thu, 2-Apr 8:30 AM)

Buy Rating on Tvardi: Differentiated STAT3 Platform, Upcoming TTI-109/TTI-101 Catalysts, and Attractive Risk-Reward Through 2026

at www.tipranks.com (Thu, 2-Apr 6:45 AM)

Tvardi Therapeutics Warns Animal Welfare Rules Could Raise Costs and Delay Drug Development

at www.tipranks.com (Thu, 2-Apr 2:00 AM)

Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD) and Forte Biosciences (FBRX)

at www.tipranks.com (Wed, 1-Apr 7:20 AM)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sotera Health (SHC), Tvardi Therapeutics (TVRD) and TruBridge (TBRG)

at www.tipranks.com (Wed, 1-Apr 7:10 AM)

Barclays Reaffirms Their Hold Rating on Tvardi Therapeutics (TVRD)

at www.tipranks.com (Wed, 1-Apr 5:27 AM)